Abstract：【Objective】To investigate the effect of salkubatrol valsartan (S/V) on heart failure with reduced ejection fraction. 【Methods】A total of 104 patients with HFREF was randomly divided into observation group and control group, with 52 cases in each group. The control group was given routine anti heart failure treatment, and the observation group was given S/V treatment on the basis of the control group. The adverse reactions, clinical efficacy after 3 months of treatment and before and after treatment and the levels of cardiac function parameters in the two groups were compared between the two groups included left atrial diameter (LA), left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), blood flow mediated vasodilation (FMD), inflammatory factors [interleukin-6 (IL-6), interleukin-33 (IL-33), and tumor necrosis factor-α(TNF-α)and intercellular adhesion factor-1 (ICAM-1)], and the rehospitalization rates of the two groups were recorded.【Results】The total effective rate in the observation group was 96.15%, higher than 75.00% in the control group, The difference was statistically significant (P<0.05). After treatment, LVEF and FMD in the two groups were higher than those before treatment, LVEDD and LA were lower than those before treatment, and the levels of serum IL-6, IL-33 and ICAM-1 in the observation group were lower than those before treatment (P<0.05) . There was no significant difference between the two groups in the total incidence of adverse reactions during treatment and rehospitalization rate within half a year of follow-up (P>0.05). 【Conclusion】The addition of S/V to HFREF on the basis of routine treatment can significantly improve the clinical efficacy, improve the cardiac function of patients, and reduce inflammatory reaction. It has good safety and is worthy of clinical promotion.
刘通, 闫泱锦, 史静怡, 王利, 张环, 冀永春. 沙库巴曲缬沙坦对射血分数降低性心衰患者心功能及炎症因子的影响[J]. 医学临床研究, 2021, 38(12): 1784-1786.
LIU Tong, YAN Yang-jin, SHI Jing-yi, et al. Effects of Salkubatrol Valsartan on Cardiac Function and Inflammatory Factors in Patients with Heart Failure Caused by Decreased Ejection Fraction. JOURNAL OF CLINICAL RESEARCH, 2021, 38(12): 1784-1786.
2021, Vol. 38 
